ALS and motor neuron disease biomarker study
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks for biological markers in people with ALS or other motor neuron diseases to better understand the different types of the disease. It may help find new ways to treat or manage these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS or another motor neuron disease.
- You live near one of the study centers.
- You are willing to take part in the study.
- You can and will come back for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with ALS or other motor neuron diseases to better understand how these conditions vary. By joining a database, you help researchers find patterns that could improve care.
This study looks at people with amyotrophic lateral sclerosis (ALS), people who might have ALS, and also people related to someone with ALS. It may help researchers better understand ALS and related “motor neuron” conditions, and it involves participation that may include blood tests.
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
This study builds a blood and spinal fluid (lumbar puncture) sample library from people with ALS, ALS-FTD, or similar neurodegenerative diseases. Your samples help researchers study these conditions, even if you are not receiving a new treatment.
This study looks at immune cells (called macrophages) from people with ALS and certain related movement or nerve conditions. It aims to better understand how the disease works and may help researchers design future treatments.
This study collects information from people diagnosed with ALS and, if applicable, studies ALS tissue samples. It aims to improve understanding of ALS using patient records and donated materials, which may help future treatments.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.